Good news! Recombinant neohirudin for injection (yeast) was awarded a major project by the municipal science and technology commission

Time:2018-10-11 Author:

Recombinant neohirudin for injection (yeast) was the earliest project of our company, and the clinical approval document was obtained in March 2016, with the approval number of 2016L01087. The project was launched in April 2018. The clinical research of the "recombinant hirudin for injection" project won the approval of Beijing municipal science and technology major special project led by Beijing municipal science and technology commission and municipal scientific research fund support.